Short-term efficacy of tacrolimus ointment in severe uremic pruritus [1]

Peritoneal Dialysis International

Volumn 20, Issue 6, 2001, Pages 802-803

  Pauli Magnus, C ^a   Klumpp, S ^a   Alscher, D M ^a   Kuhlmann U ^a   Mettang, T ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

CASE REPORT; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HUMAN; LETTER; OINTMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PRURITUS; RATING SCALE; RECURRENT DISEASE; SHORT COURSE THERAPY; UREMIA;

EID: 0035110570     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002000641     Document Type: Letter

References (5)

1. Dermatologic evaluation of pruritus in patients on hemodialysis
2. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanisms of action
3. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses
4. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures
5. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial